CH, B., E, G., KM, B., JM, K., MJ, C., RR, G., . . . M, P. (2023). Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: Case report and review of the literature. Therapeutic advances in medical oncology, 15, 17588359231193722. https://doi.org/10.1177/17588359231193722
Chicago Style (17th ed.) CitationCH, Bloomer, et al. "Exceptional Response to Cetuximab Monotherapy After Failure of Immunotherapy with a Checkpoint Inhibitor in a Patient with Metastatic Head and Neck Squamous Cell Cancer: Case Report and Review of the Literature." Therapeutic Advances in Medical Oncology 15 (2023): 17588359231193722. https://doi.org/10.1177/17588359231193722.
MLA (9th ed.) CitationCH, Bloomer, et al. "Exceptional Response to Cetuximab Monotherapy After Failure of Immunotherapy with a Checkpoint Inhibitor in a Patient with Metastatic Head and Neck Squamous Cell Cancer: Case Report and Review of the Literature." Therapeutic Advances in Medical Oncology, vol. 15, 2023, p. 17588359231193722, https://doi.org/10.1177/17588359231193722.
